Immatics NV (IMTX)
11.22
+0.52
(+4.86%)
USD |
NASDAQ |
May 20, 16:00
11.22
0.00 (0.00%)
After-Hours: 20:00
Immatics EPS Diluted (Quarterly) : -0.5023 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Epigenomics AG | -- |
| MediGene AG | -- |
| InflaRx NV | -0.0905 |
| BioNTech SE | -2.461 |
| CureVac NV | 1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.64M |
| Revenue (Quarterly) | 8.906M |
| Total Expenses (Quarterly) | 76.54M |
| Enterprise Value | 957.18M |
| Profit Margin (Quarterly) | -759.5% |
| Earnings Yield | -17.59% |
| Normalized Earnings Yield | -17.61 |